Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR8 | P51685 | 9/20 | 0.68 |
| ▸ | KCNH2 | Q12809 | 9/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 10/20 | 0.53 |
| ▸ | USP2 | O75604 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL5777024 | 0.95 | CCR8 (0.62) | CCR8KCNH2CYP2D6USP2CYP3A4 | |
| SCHEMBL5392214 | 0.95 | CCR8 (0.68) | CCR8KCNH2CYP2D6USP2CYP3A4 | |
| SCHEMBL5413974 | 0.91 | CCR8 (0.70) | CCR8KCNH2CYP2D6USP2CYP3A4 | |
| Trifluoroacetic Acid SCHEMBL5779040 | 0.90 | CCR8 (0.62) | CCR8KCNH2CYP2D6USP2CYP3A4 | |
| SCHEMBL5395604 | 0.89 | CCR8 (0.68) | CCR8KCNH2CYP2D6USP2CYP3A4 | |
| SCHEMBL5402026 | 0.89 | CCR8 (0.73) | CCR8KCNH2CYP2D6USP2CYP3A4 | |
| SCHEMBL5397396 | 0.89 | CCR8 (0.73) | CCR8KCNH2CYP2D6USP2CYP3A4 | |
| SCHEMBL5404965 | 0.88 | CCR8 (0.72) | CCR8KCNH2CYP2D6USP2CYP3A4 | |
| SCHEMBL5402122 | 0.87 | CYP2D6 (0.71) | CCR8KCNH2CYP2D6USP2CYP3A4 | |
| SCHEMBL5405018 | 0.87 | CCR8 (0.89) | CCR8KCNH2CYP2D6USP2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2007509141-A | — | — | 2007-04-12 | — | — | JP | claimed |
| EP-1678178-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | AstraZeneca AB (SE) | 2006-07-12 | — | — | EP | claimed |
| WO-2005040167-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | ASTRAZENECA AB (SE) | 2005-05-06 | — | — | WO | claimed |
| EP-1678178-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | AstraZeneca AB (SE) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005040167-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | ASTRAZENECA AB (SE) | 2005-05-06 | — | — | WO | disclosed |